Author Question: A frustrated patient in labor has been affected by decreased uterine muscle tone and reports, My ... (Read 192 times)

gonzo233

  • Hero Member
  • *****
  • Posts: 557
A frustrated patient in labor has been affected by decreased uterine muscle tone and reports, My doctor won't induce my labor because of some silly score. He said I was a 4. What kind of magic number do I need?
 
  What is the lowest Bishop score the patient should have prior to induction?
 
  a.
  6
  b.
  8
  c.
  10
  d.
  12

Question 2

What nursing assessment should be reported immediately after an amniotomy?
 
  a. Fetal heart rate is regular at 154 beats/min.
  b. Amniotic fluid is clear with flecks of vernix.
  c. Amniotic fluid is watery and pale green.
  d. Maternal temperature is 37.8  C.



mtmmmmmk

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

ANS: A
The Bishop score evaluates the suitability of the patient for a vaginal delivery. A minimum score of 6 is recommended by the American Congress of Obstetricians and Gynecologists (ACOG).

Answer to Question 2

ANS: C
Amniotic fluid should be clear. Green fluid indicates the fetus has passed meconium, which is associated with fetal compromise.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

During the twentieth century, a variant of the metric system was used in Russia and France in which the base unit of mass was the tonne. Instead of kilograms, this system used millitonnes (mt).

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library